Xin Yang

Title: Innovations of Xin Yang in Cancer Treatment

Introduction

Xin Yang is an accomplished inventor based in Duarte, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing targeted therapies that harness the power of modified T cells to combat malignancies expressing specific markers.

Latest Patents

Xin Yang holds a patent for "Targeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 positive malignancies." This patent describes chimeric antigen receptor molecules that include a variant of IL-13. The variant IL-13 is designed to be more selective for IL13Rα2 than IL13Rα1 due to its weaker binding affinity to IL13Rα1. This advancement allows for more effective treatment options for cancers that express IL13Rα2.

Career Highlights

Throughout his career, Xin Yang has worked with prestigious institutions such as City of Hope and Leland Stanford Junior University. His research has focused on innovative approaches to cancer therapy, particularly in the realm of immunotherapy.

Collaborations

Xin has collaborated with notable colleagues, including Christine E. Brown and Lawrence Stern, who have contributed to his research endeavors.

Conclusion

Xin Yang's work exemplifies the potential of targeted therapies in the fight against cancer. His innovative approaches and patented technologies pave the way for more effective treatments for patients with IL13Rα2 positive malignancies.